Human Papillomavirus Quadrivalent (types 6, 11, 16, And 18) Vaccine, Recombinant
Generic Name: human papillomavirus quadrivalent (types 6, 11, 16, and 18) vaccine, recombinant
Brand Names:
Gardasil
Dosage form: INJECTION, SUSPENSION. Route: INTRAMUSCULAR. Active ingredients: HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN (40 ug/.5mL); HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN (40 ug/.5mL); HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL); HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL). Category: BLA.
Overview
Dosage form: INJECTION, SUSPENSION. Route: INTRAMUSCULAR. Active ingredients: HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN (40 ug/.5mL); HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN (40 ug/.5mL); HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL); HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL). Category: BLA.
Dosage
Available as injection, suspension for intramuscular use.
Related Medications
Lidocaine Hcl Jelly Usp, 2%
lidocaine hcl jelly usp, 2%
Purpose Topical anesthetic
Zonisamide
zonisamide
Anti-epileptic Agent [EPC]
DESCRIPTION Zonisamide, USP is an antiseizure drug chemically classified as a sulfonamide and unrelated to other antiseizure agents. The active ingredient is zonisamide, USP, 1,2-benzisoxazole-3-methanesulfonamide. The empirical formula is C 8 H 8 N 2 O 3 S with a molecular weight of 212.23 g/mol. Zonisamide, USP is a white powder, pK a = 10.2, and is moderately soluble in water (0.80 mg/mL) and 0.1 N HCl (0.50 mg/mL).
Buprenorphine Hydrochloride
buprenorphine hydrochloride
Buprenorphine hydrochloride sublingual tablets are indicated for the treatment of opioid dependence, preferred for induction as part of a comprehensive treatment plan.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.